Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

UK biotech

This page shows the latest UK biotech news and features for those working in and with pharma, biotech and healthcare.

Digital tech from Autolus and Oxford BioMedica to speed advanced therapies

Digital tech from Autolus and Oxford BioMedica to speed advanced therapies

UK funds efforts to make country a leader in cell and gene therapy. ... A utolus, a rising star of UK biotech, is among three firms who have gained government backing to develop digital systems to bring advanced therapies into the mainstream.

Latest news

  • Boston Scientific makes $4.2bn play for UK’s BTG Boston Scientific makes $4.2bn play for UK’s BTG

    The news will be welcome for BTG shareholders, but also represents the loss of a company which has been a leading listed firm in the UK biotech and specialist pharma field ... The acquisition of BTG follows the buyout of another veteran of the UK biotech

  • UK and EU’s future relationship ‘must protect patients’ UK and EU’s future relationship ‘must protect patients’

    the spread of infectious diseases, according to the coalition, which includes representatives of the NHS and UK pharma's ABPI and biotech association the BIA. ... UK electorate with three choices on the ballot – May’s deal, no deal, or no Brexit –

  • MedCity sets up advanced therapy research network MedCity sets up advanced therapy research network

    the UK, of which around 60% are operating in the southeast of England, in the Advanced Therapies Network (ATN). ... UK companies operating int his area include university spinouts Orchard Therapeutics, Autolus, Cell Medica, GammaDelta and Quethera.

  • Warning ‘at red’ on no deal Brexit medicines chaos Warning ‘at red’ on no deal Brexit medicines chaos

    The UK pharma, biotech and generics medicines associations and the NHS’ Brexit Health Alliance and others have now called for an urgent meeting with the health secretary Matt Hancock, and say ... The EU says an agreement must be reached by the

  • What’s in store in the final (maybe short-lived) pre-Brexit budget? What’s in store in the final (maybe short-lived) pre-Brexit budget?

    The UK pharma and biotech sectors are hoping for measures to support investment in R&D and manufacturing when Chancellor Philip Hammond delivers the last pre-Brexit budget later today. ... The BIA's Steve Bates. “Many UK bioscience companies are now

More from news
Approximately 10 fully matching, plus 114 partially matching documents found.

Latest Intelligence

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    thisarea, they would also agree that recent UK GPG reporting addresses only one small part of the inequality challenge. ... Gender pay gap: not an equal paying ground. Regulatory driven though it may be, GPG reporting provides a snapshot  of gender

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    Until earlier this year she was the Chief Business Officer at Immunocore (since 2013), one of the most hotly-tipped UK biotech companies in the field of immunotherapy. ... 19. Kate Bingham, Managing Partner, SV Life Sciences. Kate is one of the

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    biology. Women setting up their own ventures still remains a rarity in biotech today, but one of the UK’s best-established trailblazers in this respect is Deborah O’Neil. ... As well as having an enduring impact on health in developing nations,

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    Dr Fiona Marshall has joined MSD from Heptares Therapeutics, the UK biotech company she co-founded more than a decade ago, which was acquired by Sosei in 2015. ... This month sees Lisa taking her years of experience to a fresh new challenge, leaving

  • Adding value to company leadership Adding value to company leadership

    At the time of our 2016 Talent Equity report, Successful Biotech Boards, we found that in UK companies, women held 16% of the seats of the 15 surveyed companies. ... None of the 25 UK and mainland European companies surveyed had a female chair.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Lisa Anson joins the UK biotech as its CEO. Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... substantial biotech company built upon an innovative science base, selectively

  • Redx Pharma appoints new chief medical officer Redx Pharma appoints new chief medical officer

    Dr Andrew Saunders joins the UK biotech from Lytix Biopharma. Drug discovery and development group Redx Pharma has appointed Dr Andrew Saunders as its chief medical officer (CMO), a role that ... He joins the UK biotech from Lytix Biopharma, a Norweigan

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio.

  • Bicycle Therapeutics appoints former Pfizer VP Maria Koehler Bicycle Therapeutics appoints former Pfizer VP Maria Koehler

    She joins the UK biotech as its chief medical officer. Bicycle Therapeutics has appointed Maria Koehler as its chief medical officer, a role that will see her lead clinical strategy and ... oversee operational functions for the UK-headquartered

  • Paul Stockdale joins Oxford BioDynamics as CFO Paul Stockdale joins Oxford BioDynamics as CFO

    He takes over from Katie Long at the UK biotech. Paul Stockdale has joined Oxford BioDynamics as its new chief financial officer and as an executive director on the UK

More from appointments
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest from PMHub

  • Lucid bolsters its senior leadership team

    Shula began working in medical communications in the USA following a successful research career in academia and the biotech industry in the UK, Germany and the USA. ... Coming back to the UK after 13 happy and successful years in America has given me the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Quick links

Infographics

Multimedia